cerebral palsy
Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations
Researchers trawled exome sequencing data to identify clinically actionable variants in 8 percent of cerebral palsy patients tested.
Exome Sequencing for Cerebral Palsy Has Sufficient Diagnostic Yield for First-Tier Test
A meta-analysis of prior studies found that the diagnostic yield of exome sequencing for cerebral palsy exceeded 31 percent, similar to other neurodevelopmental disorders.